We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

2011 Biospecimen Research Network (BRN) Symposium

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
This two-day event will feature presentations and interactive discussions about the issue of biospecimen quality and ways to address it. The symposium addresses the significant impact of pre-analytical biospecimen variables on cancer research and molecular medicine.

Hosted by NCI's Office of Biorepositories and Biospecimen Research, the meeting brings together leaders in the fields of biospecimen research, genomics, proteomics, oncology, pathology, biobanking, hospital administration and pharmaceutics as well as patient advocates.

This year's featured topics:
• Developing metrics for biospecimen quality
• Biospecimen Science and Molecular Diagnostics
• Assessing the effects of biospecimen preanalytical variables on mRNA, miRNA,
and proteins
• Collection of high quality, well annotated normal tissues for molecular research
• Tools for accessing published data in biospecimen science
• Empowering community pathologists to improve biospecimen quality

Speakers will include:
• George Poste, Chief Scientist, Complex Adaptive Systems Initiative and Professor of Health Innovation, Arizona State University
• Thomas Malone, Vice President, Transformation, College of American Pathologists
• Carolyn Compton, Director, Office of Biorepositories and Biospecimen Research,
National Cancer Institute
• Jennifer Hunt, Associate Pathologist and Associate Chief for Quality and Safety,
Massachusetts General Hospital; Associate Professor of Pathology, Harvard Medical School